xortx.com - XRTX Aggregate Business Value
This daily price chart for XORTX Therapeutics Inc. (XRTX), with a value of 0.83, is based on optimized raw material procurement via global suppliers and the establishment of warehouse reserves. The production of kidney medications has been outsourced to US contractors adhering to cGMP standards. The company's growth relies on XRx-008 trials, the fight against hyperuricemia, and the prospects for expedited FDA approval for rare pathologies.
XORTX Therapeutics Inc. (XRTX) - metric breakdowns and financial figures
- stock quotes and analyst forecast:
- issuer market value details:
- issuer book value statistics:
- company total debt and liquidity indicators:
- earnings and valuation multiples indicators:
Analysis of all company metrics:XORTX Therapeutics Inc
For XORTX Therapeutics Inc. (XRTX), the adjusted enterprise value trend reflects the market valuation of its polycystic kidney disease therapy potential, accounting for the strategic interest of pharma behemoths. This metric aggregates market capitalization and net debt to determine the actual cost of acquiring the asset, allowing investors to promptly monitor the company's financial stability and identify advantageous entry points in preparation for new clinical trial phases.
Competitors of XORTX Therapeutics Inc. (XRTX)
Value Adjusted for Debt and Cash ARGX|BNTX: Real Price to Acquire Entire Company|Abivax Pharma - Aggregate Business Value|ADMA (ADMA Biologics) - Real Price to Acquire Entire Company|Business Value PTGX|Total Company Value Immunovant|Kiniksa Pharmaceuticals, Ltd. - Full Business Value|Enterprise Value GRFS|ADPT (Adaptive Biotechnologies Inc.) - Value Adjusted for Debt and Cash|Enterprise Value CLDX (Celldex Therapeutics)|Enterprise Value auriniapharma.com AUPH|BCRX - Total Company Value|Value Adjusted for Debt and Cash VERA (Vera Therapeutics Inc)|Dianthus Pharma (DNTH) - Total Company Value|Real Price to Acquire Entire Company Pharvaris Pharma|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com|Real Price to Acquire Entire Company PGEN (Precigen)|PHAR (Pharming Group NV) - Value Adjusted for Debt and Cash|Enterprise Value NKTR (Nektar)|Company Buyout Price Upstream Pharma (UPB)|ZBIO - Total Company Value|immunome.com (IMNM) - Real Price to Acquire Entire Company|Gossamer Bio (GOSS) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|Real Price to Acquire Entire Company SEPN|Enterprise Value Pieris Corp|Total Company Value Savara Inc. (SVRA)|rigel.com - Business Value|Enterprise Value ANAB (AnaptysBio)|Astria Therapeutics Inc (ATXS) - Total Enterprise Value|ENGN: Real Price to Acquire Entire Company|RAPT (RAPT Therapeutics Inc.) - Business Value|aerovatetx.com (JBIO) - Total Company Value|Total Enterprise Value aclaristx.com (ACRS)|Total Company Value Kyverna Therapeutics, Inc.|TLSA: Value Adjusted for Debt and Cash|Real Price to Acquire Entire Company CABA (Cabaletta Bio, Inc)|Aggregate Business Value VTYX|Theratechnologies Inc. - Real Price to Acquire Entire Company|AVTX: Business Value|ELDN: Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash AGEN (Agenus, Inc.)|CLYM (Climb Bio, Inc.) - Real Price to Acquire Entire Company|ZURA: Aggregate Business Value|ATYR (aTyr Pharma, Inc.) - Enterprise Value|ADAG: Value Adjusted for Debt and Cash|Enterprise Value IMA|STTK - Total Enterprise Value|Total Company Value Equillium EQ|Value Adjusted for Debt and Cash CNTB|Immunic Inc - Enterprise Value|ATRA - Enterprise Value|inflarx.de (IFRX) - Total Company Value|Full Business Value XFOR (X4 Pharmaceuticals Inc.)|ACET (Adicet Bio Inc.) - Enterprise Value|Total Enterprise Value Celularity Corp CELU|Real Price to Acquire Entire Company INMB (INmune Bio, Inc.)|Enterprise Value barinthusbio.com (BRNS)|Kezar Life Sciences, Inc. - Real Price to Acquire Entire Company|Aggregate Business Value SABS (SAB Biotherapeutics Inc.)|Akari Therapeutics plc - Enterprise Value|Company Buyout Price Enlivex Therapeutics ENLV|QTTB: Enterprise Value|Real Price to Acquire Entire Company geovax.com|Total Company Value Edesa Biotech|iBio Inc (IBIO) - Company Buyout Price|Real Price to Acquire Entire Company CARM (Carisma Therapeutics)|XTLB (XTL Bio) - Value Adjusted for Debt and Cash|Enterprise Value BOLT (Bolt Biotherapeutics, Inc.)|Company Buyout Price HCW Biologics, Inc. (HCWB)|APVO - Total Company Value|AIM (AIM ImmunoTech, Inc.) - Business Value|ADTX: Enterprise Value|Real Price to Acquire Entire Company GRI Bio Corporation|Real Price to Acquire Entire Company HIND|revbiosciences.com (REVB) - Company Buyout Price|Real Price to Acquire Entire Company INDP (Indaptus Therapeutics, Inc.)|Scinai Immunotherapeutics Ltd - Business Value|Total Company Value CalciMedica CALI|Value Adjusted for Debt and Cash AFMD|ALLK: Real Price to Acquire Entire Company|HOOKIPA Pharma Inc. - Aggregate Business Value|IGMS (igmbio.com) - Real Price to Acquire Entire Company|Business Value ITOS|Total Company Value Ocean Bio|TC BioPharm Ltd - Full Business Value|Enterprise Value THRD